Genetic platform identifies ‘Achilles heel’ of drug-resistant Mycobacterium tuberculosis

A University of Otago-led study has found a highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering new possibilities for treatment.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup